Current Understanding of Nephrotic Syndrome in Children
- PMID: 36880923
- DOI: 10.1016/j.pcl.2022.08.002
Current Understanding of Nephrotic Syndrome in Children
Abstract
Nephrotic syndrome in children is mostly idiopathic in origin. About 90% of patients respond to corticosteroids; 80-90% have at least one relapse and 3-10% become corticosteroid resistant after the initial response. A kidney biopsy is seldom indicated for diagnosis except in patients with atypical presentation or corticosteroid resistance. For those in remission, the risk of relapse is reduced by the administration of daily low dose corticosteroids for 5-7 days at the onset of an upper respiratory infection. Some patients may continue having relapses through adult life. Many country-specific practice guidelines have been published, which are very similar with clinically insignificant differences.
Keywords: Anasarca; Children; Edema; Glomerular disease; Minimal change; Nephrotic syndrome.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have nothing to disclose.
Similar articles
-
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.Health Technol Assess. 2022 Jan;26(3):1-94. doi: 10.3310/WTFC5658. Health Technol Assess. 2022. PMID: 35060851 Clinical Trial.
-
Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.Arch Dis Child. 2016 Apr;101(4):404-8. doi: 10.1136/archdischild-2015-308924. Epub 2015 Aug 19. Arch Dis Child. 2016. PMID: 26289063 Review.
-
Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.JAMA Pediatr. 2022 Mar 1;176(3):236-243. doi: 10.1001/jamapediatrics.2021.5189. JAMA Pediatr. 2022. PMID: 34928294 Free PMC article. Clinical Trial.
-
Nephrotic syndrome.Pediatr Rev. 2015 Mar;36(3):117-25; quiz 126, 129. doi: 10.1542/pir.36-3-117. Pediatr Rev. 2015. PMID: 25733763
-
Nephrotic Syndrome.Pediatr Clin North Am. 2019 Feb;66(1):73-85. doi: 10.1016/j.pcl.2018.08.006. Pediatr Clin North Am. 2019. PMID: 30454752 Review.
Cited by
-
Enzyme-activatable kidney-targeted dendrimer-drug conjugate for efficient childhood nephrotic syndrome therapy.Theranostics. 2024 Oct 21;14(18):6991-7006. doi: 10.7150/thno.101606. eCollection 2024. Theranostics. 2024. PMID: 39629125 Free PMC article.
-
Immunosuppressive agents for frequently relapsing/steroid-dependent nephrotic syndrome in children: a systematic review and network meta-analysis.Front Immunol. 2024 Feb 23;15:1310032. doi: 10.3389/fimmu.2024.1310032. eCollection 2024. Front Immunol. 2024. PMID: 38464533 Free PMC article.
-
Network Pharmacology and Molecular Docking Validation to Explore the Pharmacological Mechanism of Zhuling Decoction against Nephrotic Syndrome.Curr Pharm Des. 2024;30(28):2244-2256. doi: 10.2174/0113816128305808240529115047. Curr Pharm Des. 2024. PMID: 38910482
-
Drug-drug interaction between diltiazem and tacrolimus in relation to CYP3A5 genotype status in Chinese pediatric patients with nephrotic range proteinuria: a retrospective study.Front Pharmacol. 2024 Sep 3;15:1463595. doi: 10.3389/fphar.2024.1463595. eCollection 2024. Front Pharmacol. 2024. PMID: 39290868 Free PMC article.
-
Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis.Front Immunol. 2023 Sep 19;14:1247606. doi: 10.3389/fimmu.2023.1247606. eCollection 2023. Front Immunol. 2023. PMID: 37795085 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources